Indicated for the treatment of nausea and vomiting of pregnancy in women aged 18 and over who do not respond to conservative management.1
Conservative management: A range of dietary and lifestyle tools to limit the symptoms.2
Adverse events should be reported. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Exeltis UK Limited on 01494 411775 or by email to uk.medinfo@exeltis.com
| Pack size3 | 20 tablets |
| Price | £28.50 |
| PIP | 408-5916 |
| GTIN | 08437018658893 |
Xonvea 10 mg/10 mg gastro resistant tablets Summary of Product Characteristics
NICE Evidence Summary ES20 Doxylamine/pyridoxine (Xonvea) for treating nausea and vomiting of pregnancy
BNF. Available at: https://bnf.nice.org.uk/drugs/doxylamine-with-pyridoxine/medicinal-forms/ (Accessed October 2024)
Find out more about Xonvea® on the product website: www.xonvea.uk
Company info
